Shenzhen Lifotronic Technology Co., Ltd. (SHA:688389)
China · Delayed Price · Currency is CNY 14.26
+0.32 (2.30%)
At close: Jan 23, 2026
SHA:688389 Revenue
Shenzhen Lifotronic Technology had revenue of 256.01M CNY in the quarter ending September 30, 2025, a decrease of -4.06%. This brings the company's revenue in the last twelve months to 1.05B, down -11.67% year-over-year. In the year 2024, Shenzhen Lifotronic Technology had annual revenue of 1.15B with 0.20% growth.
Revenue (ttm)
1.05B
Revenue Growth
-11.67%
P/S Ratio
5.80
Revenue / Employee
631.20K
Employees
1,670
Market Cap
6.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.15B | 2.32M | 0.20% |
| Dec 31, 2023 | 1.15B | 162.67M | 16.55% |
| Dec 31, 2022 | 983.04M | 204.94M | 26.34% |
| Dec 31, 2021 | 778.11M | 224.28M | 40.50% |
| Dec 31, 2020 | 553.82M | 131.18M | 31.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GKHT Medical Technology | 7.22B |
| Wuhan Huakang Century Clean Technology | 2.06B |
| Zhejiang Orient Gene Biotech | 842.11M |
| Shanghai Aohua Photoelectricity Endoscope | 671.62M |
| Hangzhou AGS MedTech | 668.70M |
| Shanghai Sanyou Medical | 512.33M |
| Contec Medical Systems Co.,Ltd | 489.91M |
| Nanjing Medlander Medical Technology | 437.82M |